News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 1913
- Sources here
- 23
- Companies here
- 22
Search results
Stored financial headlines
Active search
1913 matching headlines
Ticker or company: RHMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
iRhythm Technologies $IRTC Shares Sold by Bank of America Corp DE
Bank of America Corp DE reduced its stake in iRhythm Technologies by 41.7% in Q1, selling over 309,000 shares but still holding shares worth $51 million. Despite this reduction, iRhythm reported strong Q1 results with revenue up 20.1% year-over-year and earnings exceeding analyst expectations. …
IRTC
main company
Sharemaestro market context
Price above Trend Line
52 weeks -25.2%
The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call
The Top 5 Analyst Questions From iRhythm's Q2 Earnings Call iRhythm's second quarter results were met with a strong positive market reaction, reflecting the company's ability to deliver both robust revenue growth and significant margin improvement. Management attributed this performance to sustained demand for …
IRTC
main company
Sharemaestro market context
Price above Trend Line
52 weeks -25.2%
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by Analysts
Analysts have given iRhythm Technologies (NASDAQ:IRTC) an average recommendation of "Moderate Buy," with a consensus price target of $179.93. The company recently reported strong quarterly earnings, beating expectations with an EPS of $0.58 and revenue of $224.17 million, a 20.1% year-over-year increase. Institutional investors, …
IRTC
main company
Sharemaestro market context
Price above Trend Line
52 weeks -25.2%
Algorhythm Holdings to Announce its Financial Results for the Second Quarter of 2026
Algorhythm Holdings, Inc. (NASDAQ: RIME), a leading AI-powered logistics solutions provider, announced it will release its second-quarter financial results for the period ending June 30, 2026, on Friday, August 14, 2026. The company, through its subsidiary SemiCab, focuses on optimizing logistics for major retailers …
RIME
main company
Sharemaestro market context
Price below Trend Line
52 weeks -81.5% · Next-week setup negative 36.4%
Rhythm Pharmaceuticals (RYTM) insider outlines 10b5-1 stock sale plan in Form 144
A Rhythm Pharmaceuticals insider, Pamela Cramer, has filed a Form 144 detailing planned sales of company common stock through a 10b5-1 plan via Morgan Stanley Smith Barney LLC. The filing includes shares from stock option exercises and restricted stock units, alongside a previous sale …
RYTM
main company
Sharemaestro market context
Trend signal active
52 weeks +11.8%
iRhythm edges lower amid Spruce Point short comments
[Doctor and patient in conversation, looking at digital tablet] Solskin * iRhythm (IRTC [https://seekingalpha.com/symbol/IRTC]) ticked lower by 2% amid comments from Spruce Point Research. * iRhythm (IRTC [https://seekingalpha.com/symbol/IRTC]) didn't immediately respond to Seeking Alpha's email request for comment. * Spruce Point first issued a …
IRTC
main company
Sharemaestro market context
Price above Trend Line
52 weeks -25.2%
Rhinebeck Bancorp (RBKB): M3 entities disclose 5.21% ownership of 815,333 shares
M3 Partners, L.P., along with M3 Funds, LLC, M3F, Inc., Jason A. Stock, and William C. Waller, has reported a beneficial ownership of 815,333 shares of Rhinebeck Bancorp (RBKB) common stock, representing 5.21% of the outstanding class. The shares are directly held by M3 …
RBKB
main company
Sharemaestro market context
Stored weekly price path
4 weeks +2.2%
Algorhythm Holdings to report Q2 results
Algorhythm Holdings is scheduled to release its second-quarter 2026 financial results on August 14, 2026. This news brief was generated by Public Technologies using AI and is based on original content published by Algorhythm Holdings Inc. via GlobeNewswire. The information is for informational purposes …
RIME
main company
Sharemaestro market context
Price below Trend Line
52 weeks -81.5% · Next-week setup negative 36.4%
Algorhythm Holdings sets a date to share June-quarter results
Algorhythm Holdings (NASDAQ:RIME) announced it will release its financial results for the second quarter ended June 30, 2026, on Friday, August 14, 2026. The AI-powered logistics solutions provider shared this information from Fort Lauderdale, Florida. Prior comparable earnings-date events for the company have averaged …
RIME
main company
Sharemaestro market context
Price below Trend Line
52 weeks -81.5% · Next-week setup negative 36.4%
Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
Rhythm Pharmaceuticals, Inc. -- MHRA grants authorization for patients 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment -- BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused …
RYTM
main company
Sharemaestro market context
Trend signal active
52 weeks +11.8%
iRhythm Technologies $IRTC Shares Acquired by Quantinno Capital Management LP
Quantinno Capital Management LP significantly increased its stake in iRhythm Technologies (NASDAQ:IRTC) by 1,172.8% in the first quarter, now owning 18,621 shares valued at approximately $2.2 million. The company reported strong financial results, with quarterly revenue up 20.1% year over year to $224.17 million …
IRTC
main company
Sharemaestro market context
Price above Trend Line
52 weeks -25.2%
The Technical Signals Behind (IRTC) That Institutions Follow
This article provides a technical analysis of Irhythm Technologies Inc. (NASDAQ: IRTC), detailing institutional trading strategies based on AI models. It identifies strong near- and mid-term sentiment but a weak long-term outlook, with key support and resistance levels. The analysis also highlights a significant …
IRTC
main company
Sharemaestro market context
Price above Trend Line
52 weeks -25.2%
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Rhythm Pharmaceuticals (NASDAQ:RYTM) has received a "Moderate Buy" consensus recommendation from brokerages, with 15 out of 18 analysts rating the stock as a buy. The average 12-month price target is $142.44, exceeding the current share price of $115.48. The company reported strong quarterly revenue …
RYTM
main company
Sharemaestro market context
Trend signal active
52 weeks +11.8%
Did CRH’s (CRH) Earnings Beat, Dividend Hike and Buybacks Just Recast Its Investment Narrative?
CRH plc recently reported strong Q2 2026 results, including higher revenue and net income, a 5% dividend increase to US$0.39 per share, and reaffirmed full-year 2026 earnings guidance. The company also continues its share buyback program, demonstrating management's confidence in its cash generation. While …
CRH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -13.3%